ELEV - Elevation Oncology - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

ELEV is currently covered by 3 analysts

Elevation Oncology's activity chart (see below) currently has 3 price targets and 15 ratings on display. The stock rating distribution of ELEV is 60% BUY, 30% HOLD and 10% SELL.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 41.67% of the time, taking 62.5 days on average.

Highest price target for ELEV is $5, Lowest price target is $1.

Most recent stock forecast was given by ROBERT DRISCOLL from WEDBUSH on 03-May-2024. First documented stock forecast 20-Jul-2021.

Best performing analysts who are covering ELEV - Elevation Oncology:

Andrew Berens Robert Driscoll

Currently out of the existing stock ratings of ELEV, 3 are a HOLD (30%), 1 are a SELL (10%), 6 are a BUY (60%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$8

$8

2 years 6 months 18 days ago
(03-May-2024)

1/6 (16.67%)

$4.3 (116.22%)

59

Buy

$8

$1

3 years 5 months 22 days ago
(30-May-2023)

2/3 (66.67%)

$3.65 (83.91%)

66

Show more analysts

Please expand the browser size to see the chart

What is ELEV (Elevation Oncology) average time for price targets to be met?

On average it took 63 days for the stock forecasts to be reached, with an average price target met ratio of 41.67%.

Which analyst most recently updated their price target on ELEV (Elevation Oncology)?

Robert Driscoll

Which analyst has the lowest performance score on ELEV (Elevation Oncology) with a proven track record?

ROBERT DRISCOLL

Which analyst has the most public recommendations on ELEV (Elevation Oncology)?

Robert Driscoll works at WEDBUSH and has 16 price targets and 13 ratings on ELEV

Which analyst is the currently most bullish on ELEV (Elevation Oncology)?

Andrew Berens with the highest potential upside of $5.63
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?